Diabetes Metab Res Rev: Difference between revisions
From Bioblast
(Created page with "{{Journal |Title=[https://onlinelibrary.wiley.com/journal/15207560 Diabetes/Metabolism Reasearch and Reviews] }}") |
No edit summary |
||
| Line 1: | Line 1: | ||
{{Journal | {{Journal | ||
|Title=[https://onlinelibrary.wiley.com/journal/15207560 Diabetes/Metabolism | |Title=[https://onlinelibrary.wiley.com/journal/15207560 Diabetes/Metabolism Research and Reviews] | ||
}} | }} | ||
Latest revision as of 12:48, 29 October 2018
| Journal title and website | Diabetes/Metabolism Research and Reviews |
|---|
Publications
| Reference | Published | View | |
|---|---|---|---|
| Christensen 2018 Diabetes Metab Res Rev | Christensen M, Schiffer TA, Gustafsson H, Krag SP, Nørregaard R, Palm F (2018) Metformin attenuates renal medullary hypoxia in diabetic nephropathy through uncoupling protein-2 inhibition. Diabetes Metab Res Rev 21:e3091. | 2018 | PMID: 30345618 |
